CEACAM5 and mucinous neoplasm: Although recommended cystic fluid biomarkers, such as CEA, amylase, and glucose, contribute to diagnosing mucinous neoplasms with a higher risk of malignancy, their overall accuracy does not exceed 80% [3,5,21,33,34].